Cti Biopharm Corp
(CTIC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2017 | 12-2016 | 12-2015 | 12-2014 | 12-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 43,218 | 44,002 | 128,182 | 70,933 | 71,639 |
| Receivables | 1,278 | 8,156 | 282 | 2,011 | 235 |
| Inventories | N/A | 1,525 | 2,845 | 4,182 | 5,074 |
| TOTAL | $46,924 | $55,824 | $134,975 | $80,505 | $80,515 |
| Non-Current Assets | |||||
| PPE Net | 2,365 | 3,023 | 3,718 | 4,646 | 5,478 |
| Other Non-Current Assets | 5,597 | 4,996 | 5,504 | 7,136 | 7,730 |
| TOTAL | $7,962 | $8,019 | $9,222 | $11,782 | $13,208 |
| Total Assets | $54,886 | $63,843 | $144,197 | $92,287 | $93,723 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 444 | 7,949 | 37,371 | 9,014 | 3,155 |
| Accounts payable and accrued liabilities | 2,588 | 7,227 | 10,584 | 6,356 | 5,051 |
| Accrued Expenses | 13,890 | 24,765 | 22,133 | 19,734 | 9,469 |
| Other current liabilities | 1,424 | 602 | 1,743 | 410 | 1,384 |
| TOTAL | $19,258 | $40,646 | $72,409 | $36,340 | $20,069 |
| Non-Current Liabilities | |||||
| Long Term Debt | 13,575 | 11,311 | 19,124 | 8,363 | 10,152 |
| Deferred Revenues | 912 | 103 | 578 | 826 | 1,010 |
| Other Non-Current Liabilities | 5,630 | 4,559 | 5,482 | 6,744 | 6,464 |
| TOTAL | $19,538 | $15,440 | $24,375 | $16,024 | $17,435 |
| Total Liabilities | $38,796 | $56,086 | $96,784 | $52,364 | $37,504 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 57,983 | 28,226 | 28,056 | 18,026 | 14,964 |
| Common Shares | 43 | 2,170,300 | 2,157,300 | 2,023,949 | 1,933,305 |
| Retained earnings | -2,195,346 | -2,150,326 | -2,098,317 | -1,975,695 | -1,879,703 |
| Other shareholders' equity | -11,995 | -12,217 | -11,570 | -8,331 | 2,617 |
| TOTAL | $16,090 | $7,757 | $47,413 | $39,923 | $56,219 |
| Total Liabilities And Equity | $54,886 | $63,843 | $144,197 | $92,287 | $93,723 |